New Treatment Approach in Indian Visceral Leishmaniasis: Single-Dose Liposomal Amphotericin B Followed by Short-Course Oral Miltefosine - Sundar, Shyam; Rai, M.; Chakravarty, J.; Agarwal, D.; Agrawal, N.; Vaillant, Michel; Olliaro, Piero; Murray, Henry W. (Clinical infectious diseases, 2008)
Keywords: Adult; Amphotericin B - administration & dosage; Amphotericin B - adverse effects; Amphotericin B - therapeutic use; Antibiotics. Antiinfectious agents. Antiparasitic agents; Antifungal agents; Antimony; Antiparasitic agents; Articles and Commentaries; Biological and medical sciences; Dosage; Drug resistance; Drug therapy; Drug Therapy, Combination; Experimentation; Female; Human protozoal diseases; Humans; India; Infectious diseases; Intravenous injections; Leishmaniasis, Visceral - drug therapy; Leshmaniasis; Male; Medical cures; Medical research; Medical sciences; Parasite resistance; Parasites; Parasitic diseases; Pharmacology. Drug treatments; Phosphorylcholine - administration & dosage; Phosphorylcholine - adverse effects; Phosphorylcholine - analogs & derivatives; Phosphorylcholine - therapeutic use; Protozoal diseases; Risk reduction; Skin diseases; Sodium; Treatment Outcome; Tropical medicine; Vector-borne diseases; Visceral leishmaniasis; Asia; India; Bihar India; Antineoplastic agent; Protozoal disease; Single dose; Oral administration; Phospholipid; Kala azar; Leishmaniasis; Parasitosis; Infection; Antiprotozoal agent; Miltefosine; Antibiotic; Antifungal agent; Treatment; Amphotericin B; Polyenic compound; Lysophospholipid; Parasiticide; Indian